A supplement brand owner I know recently told me he spent six weeks vetting an ashwagandha extract supplier — only to receive a batch where the withanolide content was 40% below the certificate of analysis. The supplier blamed "natural variation." The brand ate the cost, reformulated, and started over. That's a story playing out across the industry right now, and it's a story that doesn't have to end that way.

Ashwagandha is not cooling off. According to SPINS market data, the ingredient grew 27% in the mainstream multi-outlet channel in 2025, reaching $176 million in sales. It is being formulated into male health products, stress-support blends, sleep formulas, and ready-to-drink functional beverages. Brands are piling in. The question is not whether to launch an ashwagandha product. The question is whether your supply chain can handle what comes next.

If you have been in the supplement space for a few years, you may remember the ashwagandha boom of 2021, followed by a leveling-off in 2022. Many wrote it off as a trend that peaked. They were wrong. The lifecycle of this ingredient is still unfolding, and the second wave looks different from the first.

The first wave was driven by gummies and the novelty of an "adaptogen" that promised stress relief. The second wave is being driven by something more durable: evidence. According to Kartikeya Baldwa, CEO of Ixoreal Biomed (maker of KSM-66 ashwagandha), "Ashwagandha moved from folklore to evidence. Consumers were ready for solutions that support stress resilience, sleep quality, and daily balance, but what actually unlocked wide acceptance was the category getting more disciplined about quality, consistency, and research."

Today's ashwagandha consumer is not the same as the 2021 consumer. They are looking at the Supplement Facts panel. They are turning the bottle around. They want to know the withanolide content, the extraction method, and whether the product has been clinically studied. This shift in consumer sophistication is exactly what makes supplier selection the single most important decision a brand can make.

The ashwagandha market has gone through three structural changes that directly affect how brands should approach sourcing:

"The market had to learn that 'ashwagandha' is not one uniform ingredient," explains Baldwa. "Differences in plant part, extraction process, and standardization approach can materially change what you are actually putting in a product." A root-only extract standardized to a specific withanolide profile behaves differently from a root-and-leaf blend. Brands that do not specify these parameters are gambling with batch-to-batch inconsistency.

Capsules are not going anywhere, but growth is accelerating in gummies, stick packs, ready-to-mix powders, chewables, and functional beverage formats. Each format places different demands on the extract: solubility, taste profile, heat stability, and particle size all matter. A supplier that only offers one powder specification may not be able to support your product roadmap six months from now.

"For most things, people lead with benefit," says Scott Dicker, senior director of market insights at SPINS. They search for "stress support" or "sleep quality" — and then they turn the label around to see if ashwagandha is in the formula. This means your product needs to deliver on the benefit promise consistently, and consistency starts with the ingredient.

Whether you are a startup launching your first SKU or an established brand scaling to new channels, these six questions will separate a reliable botanical extract manufacturer from a transactional supplier:

Here is a scenario we see often: a brand sources ashwagandha from Supplier A, rhodiola from Supplier B, and L-theanine from Supplier C. Three suppliers, three quality systems, three sets of documentation, and three relationships to manage. When something goes wrong — and it will — the troubleshooting multiplies.

A nutraceutical ingredient supplier that offers a broad portfolio of botanical extracts under one quality management system simplifies everything. You get consistent testing protocols, unified documentation for your own compliance needs, and a single point of contact when you need to scale. This is especially valuable for brands developing proprietary herbal formulas that combine multiple botanicals — ashwagandha with rhodiola for stress, or ashwagandha with maca for vitality. When the same R&D team understands how all the ingredients in your formula interact, the result is a more coherent product.

After years of watching brands succeed and fail with botanical ingredient sourcing, here are the signals that separate reliable partners from the rest:

Ashwagandha is at an interesting inflection point. The ingredient is well-known enough that consumers search for it by name, but still growing fast enough that there is room for new brands to enter. The category is becoming more disciplined about quality, which rewards brands that invest in sourcing over those that race to the lowest price. And the expansion into new delivery formats — functional beverages, stick packs, chewables — is creating new subcategories where the competitive landscape is not yet crowded.

The brands that win in this environment will be the ones that treat their ingredient supplier as a strategic partner, not a transactional vendor. They will ask the hard questions about standardization, plant part, extraction method, and batch consistency. They will demand documentation. And they will build relationships with suppliers who have the R&D depth to support their product roadmap — not just their next purchase order.